Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

The FDA has approved Organon’s Vtama (tapinarof) cream, 1%, for the treatment of atopic dermatitis (AD) in adults and children as young as two years of age. According to the company, the approval was ...

More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...

"With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with no ...

The Food and Drug Administration (FDA) has approved Vtama ® (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for the topical treatment of atopic dermatitis in adults and pediatric patients ...

Educational interventions for patients, including both in-person and online methods, significantly reduced atopic dermatitis (AD) severity.

There is no cure for atopic dermatitis (eczema), but there are treatments that can help manage ... Over-the-counter moisturizing creams are important for rehydrating the skin. Hydrocortisone creams ...

“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children ... You are encouraged to report negative side effects of prescription drugs to the FDA.

Atopic dermatitis (AD) remains a persistent challenge for pediatric patients ... As a phosphodiesterase-4 (PDE4) inhibitor, roflumilast cream 0.15% targets inflammation directly on the skin without ...

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead of its extended target action date of March 12, 2025, the FDA approved ...